04/05/2024
3:30 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:20 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
4:08 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
6:43 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
4:19 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:19 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:20 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/11/2024
4:20 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:16 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:52 PM | Arbet-Engels Christophe (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4/A | |
02/14/2024
6:36 PM | ORBIMED ADVISORS LLC (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
3:44 PM | ACORN BIOVENTURES, L.P. (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G | |
02/13/2024
5:55 PM | Bain Capital Life Sciences Fund, L.P. (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
4:23 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
4:23 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
3:27 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
3:28 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
4:09 PM | BlackRock Inc. (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/31/2024
1:08 PM | BlackRock Inc. (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G | |
01/08/2024
9:26 AM | Empery Asset Management, LP (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/27/2023
4:20 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
3:10 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
4:11 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
7:07 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
4:26 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:39 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:39 PM | Baldry Mark (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:40 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:42 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
7:17 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
3:04 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:15 PM | Arbet-Engels Christophe (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
11:15 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form EFFECT | |
08/16/2023
3:16 PM | Arbet-Engels Christophe (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/11/2023
6:26 PM | Stewart Murray (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
5:41 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
3:41 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
2:42 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023
2:29 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2023
3:15 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:11 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Exposed: 10 CENT Crypto to Explode April 20th? (Ad) The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%...
Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 |
06/26/2023
3:13 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
2:44 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2023
2:26 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2023
2:29 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023
11:15 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form EFFECT | |
06/16/2023
3:24 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:35 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
3:38 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
2:52 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023
3:59 PM | WYZGA MICHAEL S (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:03 PM | MCGIRR DAVID W J (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:05 PM | Bridger Gary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:10 PM | Aliski William (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
3:51 PM | Lawton Alison Frances (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
3:57 PM | de Craecker Francoise (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
3:16 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2023
2:03 PM | Growth Equity Opportunities 18 VGE, LLC (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13D/A | |
05/04/2023
3:07 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
8:05 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
5:42 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2023
3:24 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form DEFA14A | |
